Logo image of NVJP.DE

UMICORE (NVJP.DE) Stock Fundamental Analysis

Europe - FRA:NVJP - BE0974320526 - Common Stock

16.74 EUR
-0.2 (-1.18%)
Last: 10/30/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, NVJP scores 4 out of 10 in our fundamental rating. NVJP was compared to 68 industry peers in the Chemicals industry. There are concerns on the financial health of NVJP while its profitability can be described as average. NVJP has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year NVJP was profitable.
In the past year NVJP had a positive cash flow from operations.
NVJP had positive earnings in 4 of the past 5 years.
NVJP had a positive operating cash flow in each of the past 5 years.
NVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFNVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

NVJP has a Return On Assets (1.50%) which is in line with its industry peers.
With a decent Return On Equity value of 6.30%, NVJP is doing good in the industry, outperforming 60.29% of the companies in the same industry.
NVJP has a Return On Invested Capital of 6.40%. This is in the better half of the industry: NVJP outperforms 66.18% of its industry peers.
Industry RankSector Rank
ROA 1.5%
ROE 6.3%
ROIC 6.4%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
NVJP.DE Yearly ROA, ROE, ROICNVJP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

With a Profit Margin value of 0.80%, NVJP perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
With a Operating Margin value of 2.57%, NVJP perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
NVJP has a Gross Margin of 7.76%. This is amonst the worse of the industry: NVJP underperforms 83.82% of its industry peers.
In the last couple of years the Gross Margin of NVJP has grown nicely.
Industry RankSector Rank
OM 2.57%
PM (TTM) 0.8%
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
NVJP.DE Yearly Profit, Operating, Gross MarginsNVJP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NVJP is creating some value.
NVJP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, NVJP has about the same amount of shares outstanding.
Compared to 1 year ago, NVJP has a worse debt to assets ratio.
NVJP.DE Yearly Shares OutstandingNVJP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NVJP.DE Yearly Total Debt VS Total AssetsNVJP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

NVJP has an Altman-Z score of 2.79. This is not the best score and indicates that NVJP is in the grey zone with still only limited risk for bankruptcy at the moment.
NVJP has a better Altman-Z score (2.79) than 66.18% of its industry peers.
The Debt to FCF ratio of NVJP is 50.79, which is on the high side as it means it would take NVJP, 50.79 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NVJP (50.79) is comparable to the rest of the industry.
NVJP has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.10, NVJP is not doing good in the industry: 83.82% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 50.79
Altman-Z 2.79
ROIC/WACC1.05
WACC6.08%
NVJP.DE Yearly LT Debt VS Equity VS FCFNVJP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

NVJP has a Current Ratio of 1.37. This is a normal value and indicates that NVJP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NVJP (1.37) is worse than 69.12% of its industry peers.
A Quick Ratio of 0.72 indicates that NVJP may have some problems paying its short term obligations.
NVJP has a Quick ratio of 0.72. This is amonst the worse of the industry: NVJP underperforms 80.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.72
NVJP.DE Yearly Current Assets VS Current LiabilitesNVJP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

The earnings per share for NVJP have decreased strongly by -18.12% in the last year.
NVJP shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.85% yearly.
The Revenue has been growing slightly by 2.55% in the past year.
Measured over the past years, NVJP shows a decrease in Revenue. The Revenue has been decreasing by -3.21% on average per year.
EPS 1Y (TTM)-18.12%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%14.29%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-0.72%

3.2 Future

NVJP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.13% yearly.
The Revenue is expected to grow by 1.36% on average over the next years.
EPS Next Y19.15%
EPS Next 2Y12.31%
EPS Next 3Y10.33%
EPS Next 5Y7.13%
Revenue Next Year-2.58%
Revenue Next 2Y2.11%
Revenue Next 3Y1.65%
Revenue Next 5Y1.36%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NVJP.DE Yearly Revenue VS EstimatesNVJP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
NVJP.DE Yearly EPS VS EstimatesNVJP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.81 indicates a correct valuation of NVJP.
Based on the Price/Earnings ratio, NVJP is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.19. NVJP is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 12.52, the valuation of NVJP can be described as correct.
NVJP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NVJP is cheaper than 75.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.50, NVJP is valued a bit cheaper.
Industry RankSector Rank
PE 14.81
Fwd PE 12.52
NVJP.DE Price Earnings VS Forward Price EarningsNVJP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

66.18% of the companies in the same industry are more expensive than NVJP, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NVJP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 73.12
EV/EBITDA 8.41
NVJP.DE Per share dataNVJP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.77
PEG (5Y)N/A
EPS Next 2Y12.31%
EPS Next 3Y10.33%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.05%, NVJP has a reasonable but not impressive dividend return.
NVJP's Dividend Yield is a higher than the industry average which is at 3.10.
NVJP's Dividend Yield is comparable with the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 2.05%

5.2 History

The dividend of NVJP has a limited annual growth rate of 0.67%.
Dividend Growth(5Y)0.67%
Div Incr Years0
Div Non Decr Years4
NVJP.DE Yearly Dividends per shareNVJP.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

93.29% of the earnings are spent on dividend by NVJP. This is not a sustainable payout ratio.
The dividend of NVJP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP93.29%
EPS Next 2Y12.31%
EPS Next 3Y10.33%
NVJP.DE Yearly Income VS Free CF VS DividendNVJP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
NVJP.DE Dividend Payout.NVJP.DE Dividend Payout, showing the Payout Ratio.NVJP.DE Dividend Payout.PayoutRetained Earnings

UMICORE

FRA:NVJP (10/30/2025, 7:00:00 PM)

16.74

-0.2 (-1.18%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)02-03 2026-02-03/amc
Inst Owners35.32%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.12B
Revenue(TTM)16.10B
Net Income(TTM)128.82M
Analysts66.67
Price Target14.26 (-14.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.05%
Yearly Dividend0.8
Dividend Growth(5Y)0.67%
DP93.29%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.15%
PT rev (3m)6.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)23.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)2.89%
Valuation
Industry RankSector Rank
PE 14.81
Fwd PE 12.52
P/S 0.26
P/FCF 73.12
P/OCF 8.78
P/B 2.02
P/tB 2.48
EV/EBITDA 8.41
EPS(TTM)1.13
EY6.75%
EPS(NY)1.34
Fwd EY7.99%
FCF(TTM)0.23
FCFY1.37%
OCF(TTM)1.91
OCFY11.39%
SpS65.35
BVpS8.29
TBVpS6.75
PEG (NY)0.77
PEG (5Y)N/A
Graham Number14.52
Profitability
Industry RankSector Rank
ROA 1.5%
ROE 6.3%
ROCE 8.18%
ROIC 6.4%
ROICexc 8.19%
ROICexgc 9.07%
OM 2.57%
PM (TTM) 0.8%
GM 7.76%
FCFM 0.35%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
F-Score5
Asset Turnover1.87
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 50.79
Debt/EBITDA 3.22
Cap/Depr 144.97%
Cap/Sales 2.57%
Interest Coverage 4.12
Cash Conversion 67.19%
Profit Quality 43.79%
Current Ratio 1.37
Quick Ratio 0.72
Altman-Z 2.79
F-Score5
WACC6.08%
ROIC/WACC1.05
Cap/Depr(3y)224.12%
Cap/Depr(5y)196.78%
Cap/Sales(3y)3.57%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.12%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%14.29%
EPS Next Y19.15%
EPS Next 2Y12.31%
EPS Next 3Y10.33%
EPS Next 5Y7.13%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-0.72%
Revenue Next Year-2.58%
Revenue Next 2Y2.11%
Revenue Next 3Y1.65%
Revenue Next 5Y1.36%
EBIT growth 1Y136.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.86%
EBIT Next 3Y23.57%
EBIT Next 5Y16.17%
FCF growth 1Y136.84%
FCF growth 3Y-30.19%
FCF growth 5YN/A
OCF growth 1Y-3.36%
OCF growth 3Y-11.62%
OCF growth 5Y12.64%

UMICORE / NVJP.DE FAQ

What is the ChartMill fundamental rating of UMICORE (NVJP.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NVJP.DE.


What is the valuation status for NVJP stock?

ChartMill assigns a valuation rating of 5 / 10 to UMICORE (NVJP.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for UMICORE?

UMICORE (NVJP.DE) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for NVJP stock?

The Price/Earnings (PE) ratio for UMICORE (NVJP.DE) is 14.81 and the Price/Book (PB) ratio is 2.02.


What is the financial health of UMICORE (NVJP.DE) stock?

The financial health rating of UMICORE (NVJP.DE) is 3 / 10.